• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BET
Click for more information
1.14% 8.9¢

BETMAKERS TECHNOLOGY GROUP LTD

Market Cap $86.86M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Cyclical Resorts & Casinos

BetMakers Technology Group Ltd is an international provider of advanced wagering... BetMakers Technology Group Ltd is an international provider of advanced wagering technology, data, content, and service solutions with a footprint that spans the racing and betting markets. The Company is engaged in the development and provision of software, data, and analytic products for the business-to-business (B2B) wagering market and the production and distribution of racing content. Its segments include Global Betting Services, Global Tote, and corporate. The Global Betting Services segment provides customers with a variety of racing software, data, and analytical tools. This includes basic race data, such as pricing, runners, and form, as well as analytical tools to consume and leverage the data, and wagering tools, such as platforms and managed trading services. It also assists racing bodies and rights holders in producing and distributing race content. The Global Tote segment includes the provision of tote software and integrations to facilitate tote liquidity and resulting. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BET
Ann: Appendix 3Y 		10:35 3 476
10:35 Last post  ibetfixed Comments Created with Sketch.  3  Views Created with Sketch.  476 
BET
Ann: Amended Securities Trading Policy 		19/09/24 9 2.0K
19/09/24 Last post  rustic Comments Created with Sketch.  9  Views Created with Sketch.  2.0K 
BET
Hey Google, is BET the most corrput ASX listed company? 		17/09/24 12 3.3K
17/09/24 Last post  cambam Comments Created with Sketch.  12  Views Created with Sketch.  3.3K 
BET
Ann: Closing of Director Funding Facility 		16/09/24 12 3.9K
16/09/24 Last post  Kdogg Comments Created with Sketch.  12  Views Created with Sketch.  3.9K 
BET
Betmakers Chart
20 21 22
13/09/24 1.2K 444K
13/09/24 Last post  Biloselhi Comments Created with Sketch.  1.2K  Views Created with Sketch.  444K 
BET
Ann: Appendix 3Y 		13/09/24 0 236
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  236 
BET
Ann: Change in substantial holding 		13/09/24 0 265
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  265 
BET
Ann: Appendix 4E and Annual Report 		10/09/24 12 3.2K
10/09/24 Last post  Muza Comments Created with Sketch.  12  Views Created with Sketch.  3.2K 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 3Y
20 Sep 09:33
 
Amended Securities Trading Policy
17 Sep 15:25
 
Closing of Director Funding Facility
13 Sep 08:30
 
Appendix 3Y
13 Sep 08:25
 
Change in substantial holding
13 Sep 08:25
 
Appendix 4G
30 Aug 08:28
 
View More arrow Created with Sketch.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
(20min delay)
Last
8.9¢ 		Change
0.001(1.14%) 		Mkt cap ! $86.86M
Open High Low Value Volume
8.8¢ 9.0¢ 8.8¢ $18.18K 202.6K

Buyers (Bids)

No. Vol. Price($)
2 108313 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 45188 1
View Market Depth
Last trade - 12.25pm 20/09/2024 (20 minute delay) ?
Last
8.9¢ 		  Change
0.001 ( 1.14 %)
Open High Low Volume
9.0¢ 9.0¢ 8.8¢ 114903
Last updated 12.25pm 20/09/2024 ?
BET (ASX) Chart

Top Stories

Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025

Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.

Featured News

NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.